| |
Arq Bras Endocrinol Metabol, Vol. 49, No. 5. (October 2005), pp. 613-614.
|
| |
J Natl Cancer Inst, Vol. 92, No. 10. (17 May 2000)
|
| |
Clin Chem, Vol. 48, No. 8. (August 2002), pp. 1147-1150.
|
| |
NeuroRx, Vol. 1, No. 2. (April 2004), pp. 189-195.
|
| |
Toxicol Pathol, Vol. 32 Suppl 1 (r 2004), pp. 116-121.
|
| |
Mol Cell Proteomics, Vol. 3, No. 4. (April 2004), pp. 345-354.
|
| |
Toxicol Pathol, Vol. 32 Suppl 1 (r 2004), pp. 1-2.
|
| |
Clin Chem, Vol. 50, No. 5. (May 2004), pp. 793-795.
|
| |
IARC Sci Publ, No. 157. (2004), pp. 437-450.
|
| |
Mol Pharm, Vol. 3, No. 1. (b 2006), pp. 26-32.
|
| |
Pharmacogenomics, Vol. 7, No. 1. (January 2006), pp. 117-122.
|
| |
AAPS J, Vol. 8, No. 1. (2006)
|
| |
Ther Drug Monit, Vol. 28, No. 1. (February 2006), pp. 35-38.
|
| |
Pharm Res, Vol. 23, No. 2. (February 2006), pp. 312-328.
by J. W. Lee, V. Devanarayan, Y. C. Barrett, et al.R. Weiner, J. Allinson, S. Fountain, S. Keller, I. Weinryb, M. Green, L. Duan, J. A. Rogers, R. Millham, P. J. O'Brien, J. Sailstad, M. Khan, C. Ray, J. A. Wagner
|
| |
Expert Rev Proteomics, Vol. 3, No. 1. (February 2006), pp. 45-62.
|
| |
Eur J Clin Pharmacol, Vol. 62, No. 2. (February 2006), pp. 91-95.
|
| |
Nippon Yakurigaku Zasshi, Vol. 127, No. 3. (March 2006), pp. 217-221.
|
| |
J Proteome Res, Vol. 5, No. 3. (March 2006), pp. 461-462.
|
| |
Expert Review of Molecular Diagnostics, Vol. 6, No. 2. (March 2006), pp. 179-191.
|
| |
Mol Cell Proteomics (17 March 2006)
|
| |
Biochem Soc Trans, Vol. 34, No. Pt 2. (April 2006), pp. 313-316.
|
| |
Nature Reviews Drug Discovery, Vol. 5, No. 5. (21 April 2006), pp. 377-380.
|
| |
Proteomics, Vol. 6, No. 10. (May 2006), pp. 2947-2958.
|
| |
Nature, Vol. 441, No. 7092. (24 May 2006), pp. 451-456.
|
| |
Mol Cell Proteomics (29 May 2006)
|
| |
Drug Discov Today, Vol. 11, No. 11-12. (June 2006), pp. 550-555.
|
| |
Curr Pharm Biotechnol, Vol. 7, No. 3. (June 2006), pp. 147-158.
|
| |
Curr Drug Metab, Vol. 7, No. 5. (June 2006), pp. 525-539.
|
| |
J Clin Pharmacol, Vol. 43, No. 4. (April 2003), pp. 329-341.
|
| |
|
| |
J Endocrinol, Vol. 186, No. 1. (July 2005), pp. 1-20.
|
| |
Mol Pharmacol, Vol. 67, No. 5. (May 2005), pp. 1383-1384.
|
| |
Biochem J, Vol. 385, No. Pt 3. (1 February 2005), pp. 625-637.
|
| |
Br J Pharmacol, Vol. 143, No. 2. (September 2004), pp. 235-245.
|
| |
Mol Pharmacol, Vol. 66, No. 1. (1 July 2004), pp. 1-7.
|
| |
Curr Opin Drug Discov Devel, Vol. 4, No. 5. (September 2001), pp. 561-574.
|
| |
Biochem J, Vol. 374, No. Pt 2. (1 September 2003), pp. 281-296.
|
| |
Annual review of physiology, Vol. 65 (2003), pp. 851-879.
|
| |
Pharmacol Rev, Vol. 54, No. 2. (June 2002), pp. 323-374.
|
| |
J Am Osteopath Assoc, Vol. 105, No. 9. (September 2005), pp. 409-416.
|
| |
Folia Neuropathol, Vol. 43, No. 3. (2005), pp. 193-196.
|
| |
NeuroRx, Vol. 1, No. 2. (April 2004), pp. 182-188.
|
| |
NeuroRx, Vol. 2, No. 4. (October 2005), pp. 683-695.
|
| |
NeuroRx, Vol. 2, No. 4. (October 2005), pp. 579-589.
|
| |
NeuroRx, Vol. 2, No. 4. (October 2005), pp. 627-637.
|
| |
Nat Biotech, Vol. 22, No. 10. (October 2004), pp. 1249-1252.
|
| |
Proteome Science, Vol. 4, No. 1. (04 April 2006), 5.
|
| |
The EMBO Journal, Vol. aop, No. current. (27 January 2005)
|
| |
The Journal of Physiology, Vol. 563, No. 1. (February 2005), pp. 11-21.
|
| |
J Exp Bot, Vol. 56, No. 410. (January 2005), pp. 245-254.
|